Abstract
EE47 Cost-Effectiveness of Abiraterone, Enzalutamide, and Apalutamide in Metastatic Castration-Sensitive Prostate Cancer (MCSPC): A Partitioned-Survival Model
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have